# Statin and Atheroma Vulnerability Evaluation

> **NCT00997880** · PHASE4 · COMPLETED · sponsor: **Seung-Jung Park** · enrollment: 312 (actual)

## Conditions studied

- Coronary Artery Disease

## Interventions

- **DRUG:** Rosuvastatin calcium 40mg
- **DRUG:** Rosuvastatin calcium10mg

## Key facts

- **NCT ID:** NCT00997880
- **Lead sponsor:** Seung-Jung Park
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-04
- **Primary completion:** 2014-12
- **Final completion:** 2014-12
- **Target enrollment:** 312 (ACTUAL)
- **Last updated:** 2014-12-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00997880

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00997880, "Statin and Atheroma Vulnerability Evaluation". Retrieved via AI Analytics 2026-07-25 from https://api.ai-analytics.org/clinical/NCT00997880. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*